الصفحة الرئيسية>>Proteins>> Enzymes>> Phosphatase>>MLS000544460

MLS000544460

رقم الكتالوجGC61408

MLS000544460 هو مثبط Eya2 الفوسفاتيز انتقائي للغاية وقابل للانعكاس مع Kd 2.0 ميكرومتر و IC50 من 4 ميكرومترMLS000544460 يمنع هجرة الخلايا Eya2 فسفاتيز بوساطة وله نشاط مضاد للسرطان

Products are for research use only. Not for human use. We do not sell to patients.

MLS000544460 التركيب الكيميائي

Cas No.: 352336-36-8

الحجم السعر المخزون الكميّة
5 mg
232٫00
متوفر
10 mg
417٫00
متوفر
25 mg
788٫00
متوفر
50 mg
1251٫00
متوفر
100 mg
1808٫00
متوفر

Tel:(909) 407-4943 Email: sales@glpbio.com

مراجعات العميل

بناء على آراء العملاء.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

MLS000544460 is a highly selective and reversible Eya2 phosphatase inhibitor with a Kd of 2.0 μM and an IC50 of 4 μM. MLS000544460 inhibit Eya2 phosphatase mediated cell migration and has anti-cancer activity[1].

MLS000544460 does not bind Eya3 phosphatase (ED)[1]. MLS000544460 (10 μM) inhibits Eya2-mediated cell migration in human Eya2, Eya2 phosphatase-dead (D274N), and YFP (as a negative control) expressing MCF10A cells[1]. When Eya2 ED is dialyzed into 10 μM EDTA to remove Mg2+, it binds MLS000544460 with a higher affinity (Kd=0.80 μM), indicating that this class of compounds does not require Mg2+ for its interaction with the Eya2 ED[1].

[1]. Krueger AB, et al. Allosteric inhibitors of the Eya2 phosphatase are selective and inhibit Eya2-mediated cellmigration. J Biol Chem. 2014 Jun 6;289(23):16349-61.

مراجعات

Review for MLS000544460

Average Rating: 5 ★★★★★ (Based on Reviews and 9 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for MLS000544460

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.